M&A Deal Summary |
|
|---|---|
| Date | 2015-07-31 |
| Target | X-spine Systems |
| Sector | Medical Products |
| Buyer(s) | Xtant Medical |
| Deal Type | Add-on Acquisition |
| Deal Value | 60M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Sector | Medical Products |
| Employees | 110 |
| Revenue | 58M USD (2022) |
Xtant Medical is a developer of biologics products to domestic and international markets. Xtant Medical is based in Belgrade, Montana.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Medical Products) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (Ohio) | 1 of 1 |
| Country (United States) | 1 of 2 |
| Year (2015) | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-03-01 |
Surgalign s Coflex Product Line
Deerfield, Illinois, United States Surgalign's Coflex Product Line comprises interlaminar stabilization device used after an open decompression that can be performed in various settings, offering a non-fusion treatment option for lumbar spinal stenosis (LSS) patients. The number of patients diagnosed globally with LSS is approximately 2.4 million representing the largest single-growing patient demographic in spine. The Coflex device is the only FDA PMA-approved implant for the treatment of LSS, has been implanted in more than 200,000 patients in over 60 countries, is clinically validated with more than 90 peer reviewed publications and has established Ambulatory Surgery Center (ASC) reimbursement. Cofix is a supplemental fixation device, which is a minimally invasive system intended for use on all levels of the lumbar spine. |
Buy | $17M |
